AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
Gold Prices Rise as Fed Rate Hike Bets Ease 
England Drought Expands to 71% as Heatwave Deepens Water Crisis 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
S&P 500, Nasdaq Futures Rise as Iran Risks and CPI Loom 
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants 
Maduro U.S. Drug Trafficking Trial Set for June 2027 as Immunity Defense Looms 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
Peru Court Frees Former President Ollanta Humala After Conviction Overturned 
Asian Currencies Steady as Markets Await U.S. Inflation Data 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
